-

Tenet Healthcare Appoints Senator Roy Blunt to Board of Directors

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of Senator Roy Blunt to the Tenet Board of Directors, effective immediately. Senator Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. This appointment expands the Board to 12 directors, 11 of whom are independent members.

“We are pleased to welcome Senator Roy Blunt as a new board member,” said Saum Sutaria, M.D., Chief Executive Officer of Tenet. “With more than 25 years of legislative experience, Roy’s expertise in public policy and addressing cross-cutting issues will be invaluable to helping Tenet make a lasting, positive impact on the communities we serve while also increasing long-term value for our shareholders.”

Senator Blunt is currently the Chairman of the Leadership Advisory Strategies group at Husch Blackwell Strategies. Senator Blunt was elected to the U.S. House of Representatives in 1996 and U.S. Senate in 2010, consistently demonstrating his commitment to serving the public with unwavering integrity and purpose. Throughout his career, Senator Blunt has spearheaded major legislative achievements in health care and other highly regulated industries, with a commitment to medical research and discovery.

Senator Blunt served on committees in Congress where his leadership helped shape key policies. This includes service as Chairman of the Senate Rules Committee as well as serving on the Senate Appropriations Committee, Senate Commerce, Science and Transportation Committee, and the Senate Select Committee on Intelligence. Notably, Senator Blunt was Chairman of the Appropriations Subcommittee on Labor, Health and Human Services, and Education, underscoring his focus on health care and health research. During his eight years on the subcommittee, Senator Blunt focused resources and awareness on critical issues including increasing funding for medical research centers and Alzheimer’s disease research.

Prior to his tenure in Congress, he was a history teacher, county official, and Missouri’s Secretary of State. Senator Blunt also served four years as the president of Southwest Baptist University. Senator Blunt is actively involved in promoting and preserving the arts and history. He has served as a member of the Smithsonian Council for American Art, as President of the State Historical Society of Missouri, and as a member of the Kennedy Center Board of Trustees.

Senator Blunt is an Executive Fellow at the Bipartisan Policy Center in Washington, D. C. He also chairs the Advisory Board of the National Geospatial Agency of the U. S. Government and serves on the Southwest Airlines Board of Directors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 475 ambulatory surgery centers and surgical hospitals. We also operate 61 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve. For more information, please visit www.tenethealth.com.

Contacts

Investor Contact
Will McDowell
469-893-2387
William.McDowell@tenethealth.com

Media Contact
Robert Dyer
469-893-2640
mediarelations@tenethealth.com

Tenet Healthcare Corporation

NYSE:THC

Release Versions

Contacts

Investor Contact
Will McDowell
469-893-2387
William.McDowell@tenethealth.com

Media Contact
Robert Dyer
469-893-2640
mediarelations@tenethealth.com

More News From Tenet Healthcare Corporation

Tenet Announces Upsizing and Pricing of Its $2.25 Billion Private Offerings of Senior Secured Notes and Senior Notes

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.5 billion in aggregate principal amount of senior secured first lien notes due on November 15, 2032, which will bear interest at a rate of 5.500% per annum (the “first lien notes”), and $0.75 billion in aggregate principal amount of senior notes due November 15, 2033, which will bear interest at a rate of 6.000%...

Tenet Announces Private Offerings of Senior Secured Notes and Senior Notes to Refinance $2.0 Billion in Outstanding Notes

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced private placement offerings of $1.5 billion in aggregate principal amount of new senior secured first lien notes due 2032 (the “first lien notes”) and $0.5 billion in aggregate principal amount of new senior notes due 2033 (the “senior notes” and together with the first lien notes, the “notes”) to refinance $2.0 billion of its currently outstanding notes. Completion of the notes offering is subject to, among other...

Tenet Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2025. "Our high acuity service line focus and operational discipline enabled us to deliver strong same store revenue growth and attractive operational performance and free cash flow in the third quarter," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We are well positioned for continued growth as we execute on our strategy in each o...
Back to Newsroom